Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Shandong Xinhua Pharmaceutical Co Ltd
HKEX:719
Shandong Xinhua Pharmaceutical Co Ltd
HKEX:719
Price:
5.705
HKD
0.26%
Market Closed
Market Cap:
HK$10.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shandong Xinhua Pharmaceutical Co Ltd
HKEX:719
|
CN |
|
M
|
Momentum Group AB
OTC:MMGRF
|
SE |
|
T
|
Torm PLC
F:1T4
|
UK |
|
C
|
COSCO SHIPPING Ports Ltd
OTC:CSPKY
|
HK |
|
OODA AI publ AB
F:G7H0
|
SE |
|
C
|
COSCO SHIPPING Ports Ltd
DUS:CTH
|
HK |
Wall St Price Targets
Price Forecast
Based on 3 analysts
Based on 3 analysts
-29% Downside
from
HK$5.705
today
Shandong Xinhua Pharmaceutical Co Ltd (719)’s 12-month stock price forecast through September 2027 has a consensus target of HK$4.027, implying 29% downside. The forecast is based on price targets from 3 Wall Street analysts.
Analyst Rating
No ratings yet
No ratings yet
Shandong Xinhua Pharmaceutical Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Shandong Xinhua Pharmaceutical Co Ltd's stock price target?
Price Target
4.027
HKD
4.027
HKD
According to Wall Street analysts, the average 1-year price target for Shandong Xinhua Pharmaceutical Co Ltd is 4.027 HKD with a low forecast of 3.987 HKD and a high forecast of 4.145 HKD.
What is the Revenue forecast for Shandong Xinhua Pharmaceutical Co Ltd?
Projected CAGR
2%
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 2 years is 2%.
What is the Operating Income forecast for Shandong Xinhua Pharmaceutical Co Ltd?
Projected CAGR
25%
25%
Over the last 13 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 2 years is 25%.
What is the Pre-Tax Income forecast for Shandong Xinhua Pharmaceutical Co Ltd?
Projected CAGR
43%
43%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 2 years is 43%.
What is the Net Income forecast for Shandong Xinhua Pharmaceutical Co Ltd?
Projected CAGR
47%
47%
Over the last 13 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 2 years is 47%.